‘Inflammatory Processes &
Cardiovascular Disease
-Innovative Healthcare for Challenging Times’
Date: 10th & 11th May 2012
Venue: City Hotel, Derry/Londonderry, N.Ireland, UK
Celebrating its fourth successful year, the event is recognised as a leading international conference in translational medicine. Over 160 international delegates including clinicians, academics and businesses attended in 2011 from USA, UK, Ireland, Mainland Europe and Asia and the conference continues to grow in stature each year.
A better understanding of the role of inflammation in the pathogenesis of a range of disease processes, including cardiovascular disease has led to the development of novel biomarkers and innovative approaches to treatment. Building on the themes explored last year, our 4th Annual Translational Medicine Conference will have a dual focus on Inflammatory Processes and Cardiovascular Disease and there will be dedicated tracks addressing both areas.
The conference will also explore the interplay between inflammation and cardiovascular disease and the translation of these new concepts into the clinical domain. The conference targets academics, clinicians, researchers and bioindustry R&D managers with the aim of encouraging collaboration and communication to inform research and clinical interventions.
In addition to focusing on the specific disease processes and areas outlined above, other topics covered will include:
- Open innovation in bioscience
- The increasing role of technology/apps in disease management
- Leading trends in healthcare innovation
- Regulatory and governance issues
- Challenges and obstacles in translational medicine
Programme Outline
(Full Conference programme will be available shortly, please click on a date below for details)
Thursday 10th May
Friday 11th May
Confirmed Speakers to Date:
CEO, Stevenage Bioscience Catalyst
CEO, Healthrageous, US
Managing Director, Randox Laboratories (TBC)
Director, Diagnostics Assessment Programme Centre for Health Technology Evaluation
National Institute for Clinical Excellence
Director of Research & Development.
Department of Health, Social Services and Public Safety;
President, European Society of Pharmacogenomics & Theranostics (ESPT), FRANCE
Professor/Director of MRC Methodology Hub, Queen’s University, Belfast
Executive Director, Business Development, Partners HealthCare, US
Director of the Clinical Research Facility, Queen’s University, Belfast;
Consultant Rheumatologist, Western Health and Social Care Trust
Research Associate in Stratified Medicine, University of Ulster
Reader, Computer Science Research Institute, University of Ulster
Senior Vice President at Moderna Therapeutics , Principal, Founder at Whoriskey Associates and former Entrepreneur in Residence (Life Sciences) at MIT
School of Biotechnology and Biomedical Diagnostics Institute, Dublin City University
CEO at Intelesens Ltd
Chief Executive, Health Research Board
Consultant Cardiologist, Western Health and Social Care Trust
Director of R&D, Western Health and Social Care Trust and Chief Executive, C-TRIC
Managing Director, Randox Laboratories
Consultant Cardiologist, Craigavon Hospital
More speaker confirmations to follow soon….
Registration Fee:
Early Bird before 02/03/12 = £50.00;
Full Registration Fee = £85.00;
Registration Fee for WHSCT/UU Staff = £45.00
Please contact info@c-tric.com for further information.
Follow Us!